Henry Ji

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Stephen Ma, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Henry Ji

Form 4 holding President, CEO and Chairman of the Board of Directors, Director

Sorrento Therapeutics, Inc.

Security class
Common Stock
Shares / value
6,265,805
Estimated value
$5,029,562
Report date
17 Mar 2023
Price
$0.8027
Ownership
Direct
Form 4 holding President, CEO and Chairman of the Board of Directors, Director

Sorrento Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,271,693
Estimated value
$1,823,488
Report date
17 Mar 2023
Price
$0.8027
Ownership
Indirect
Form 4 holding Exec Chair, CEO and President, Director

Scilex Holding Co

Security class
Warrant (right to buy)
Shares / value
2,600,000
Estimated value
$399,880
Report date
17 Apr 2026
Price
$0.1538
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Exec Chair, CEO and President, Director

Scilex Holding Co

Security class
Common Stock
Shares / value
320,161
Estimated value
$300,823
Report date
31 Oct 2024
Price
$0.9396
Ownership
Direct
Form 4 holding Exec Chair, CEO and President, Director

Scilex Holding Co

Security class
Common Stock
Shares / value
292,264
Estimated value
$274,611
Report date
31 Oct 2024
Price
$0.9396
Ownership
Indirect
Form 4 holding President, CEO and Chairman of the Board of Directors, Director

Sorrento Therapeutics, Inc.

Security class
Common Stock
Shares / value
40,000
Estimated value
$32,108
Report date
17 Mar 2023
Price
$0.8027
Ownership
By spouse
Form 4 holding President, CEO and Chairman of the Board of Directors, Director

Sorrento Therapeutics, Inc.

Security class
Common Stock
Shares / value
20,000
Estimated value
$16,054
Report date
17 Mar 2023
Price
$0.8027
Ownership
By BioVintage, Inc.
Form 4 holding Exec Chair, CEO and President, Director

Scilex Holding Co

Security class
Common Stock
Shares / value
5,640
Estimated value
$5,299
Report date
31 Oct 2024
Price
$0.9396
Ownership
By Spouse
Form 4 holding Exec Chair, CEO and President, Director

Scilex Holding Co

Security class
Common Stock
Shares / value
2,749
Estimated value
$2,583
Report date
31 Oct 2024
Price
$0.9396
Ownership
By BioVintage, Inc.
Form 4 holding Exec Chair, CEO and President, Director

Scilex Holding Co

Security class
Incentive Stock Option (right to buy)
Shares / value
120,000
Estimated value
Report date
08 Oct 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman of the Board of Directors, Director

Sorrento Therapeutics, Inc.

Security class
Put Option (obligation to buy)
Shares / value
0
Estimated value
Report date
17 Mar 2023
Price
Ownership
By BioVintage, Inc.
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Henry Ji

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .